Publications Breadcrumb Home Publications Since we carefully research publications with DZIF affiliation before posting them on the DZIF website, there is usually a delay of two to three months between a paper's publication date and its listing on the DZIF publications website. Show filterHide filter All years of publication All years of publication20122013201420152016201720182019202020212022202320242025 All research areas All research areasCommunity-Acquired Infections at Mucosal InterfacesHepatitisHIVInfections of the Immunocompromised HostHealthcare-Associated InfectionsMalaria and Neglected Tropical DiseasesEmerging InfectionsNovel AntibioticsTuberculosis All infrastructures All infrastructuresBioresources, Biodata and Digital HealthDZIF AcademyClinical Trial UnitProduct Development Jan 2022 mBio Overcoming the Barrier of the Respiratory Epithelium during Canine Distemper Virus Infection Autoren Shin DL et al. Jan 2022 Internist (Berl) [Practical use of digital health applications (DiGA) in internal medicine] Autoren Mittermaier M et al. Jan 2022 Infect Genet Evol Molecular epidemiology of respiratory syncytial virus in hospitalised children in Heidelberg, Southern Germany, 2014-2017 Autoren Tabatabai J et al. Jan 2022 Euro Surveill Impact of single-room contact precautions on acquisition and transmission of vancomycin-resistant enterococci on haematological and oncological wards, multicentre cohort-study, Germany, January−December 2016 Autoren Biehl LM et al. Jan 2022 PLoS One Longitudinal variability in the urinary microbiota of healthy premenopausal women and the relation to neighboring microbial communities: A pilot study Autoren Biehl LM et al. Jan 2022 Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz [Bulevirtide as the first specific agent against hepatitis D virus infections-mechanism and clinical effect] Autoren Nkongolo S Hollnberger J Urban S Jan 2022 PLoS Pathog Advances and gaps in SARS-CoV-2 infection models Autoren Muñoz-Fontela C et al. Jan 2022 Mol ther Ex vivo and in vivo suppression of SARS-CoV-2 with combinatorial AAV/RNAi expression vectors Autoren Becker J et al. Jan 2022 Commun Biol SARS-CoV-2 infection induces a pro-inflammatory cytokine response through cGAS-STING and NF-κB Autoren Neufeldt CJ et al. Jan 2022 Chem Sci Total synthesis and mechanism of action of the antibiotic armeniaspirol A Autoren Arisetti N et al. Jan 2022 Clin Exp Immunol Deciphering the Plasmodium falciparum malaria-specific CD4+ T cell response: ex vivo detection of high frequencies of PD-1+TIGIT+ EXP1-specific CD4+ T cells using a novel HLA-DR11-restricted MHC class II tetramer Autoren Schulte S et al. Jan 2022 PLoS Pathog Itaconate and derivatives reduce interferon responses and inflammation in influenza A virus infection Autoren Sohail A et al. Jan 2022 J Virol Reduction of CD8 T cell functionality but not inhibitory capacity by integrase inhibitors Autoren Richter E et al. Jan 2022 J Antimicrob Chemother An open randomized multicentre Phase 2 trial to assess the safety of DAV132 and its efficacy to protect gut microbiota diversity in hospitalized patients treated with fluoroquinolones Autoren Vehreschild M et al. Jan 2022 Nat Commun Dynamics of spike-and nucleocapsid specific immunity during long-term follow-up and vaccination of SARS-CoV-2 convalescents Autoren Koerber N et al. Jan 2022 Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz [Development approaches for vaccines against hepatitis C virus infections] Autoren Bankwitz D Krey T Pietschmann T Jan 2022 Parasitol Res A qPCR to quantify Wolbachia from few Onchocerca volvulus microfilariae as a surrogate for adult worm histology in clinical trials of antiwolbachial drugs Autoren Schlabe S et al. Jan 2022 Hepatology HCC and HBV reactivation-A preventable condition not to be missed Autoren Sandmann L Cornberg M Jan 2022 Bioorg Med Chem Lett Novel 2,4-disubstituted quinazoline analogs as antibacterial agents with improved cytotoxicity profile: Modification of the benzenoid part Autoren Megahed SH et al. Jan 2022 Front Immunol Editorial: Novel Concepts in Using Broadly Neutralizing Antibodies for HIV-1 Treatment and Prevention Autoren Wagh K et al. Jan 2022 Cell Mol Immunol MCMV-based vaccine vectors expressing full-length viral proteins provide long-term humoral immune protection upon a single-shot vaccination Autoren Kim Y et al. Jan 2022 Cell mRNA-based COVID-19 vaccine boosters induce neutralizing immunity against SARS-CoV-2 Omicron variant Autoren Garcia-Beltran WF et al. Jan 2022 Gut Pathog Myxopyronin B inhibits growth of a Fidaxomicin-resistant Clostridioides difficile isolate and interferes with toxin synthesis Autoren Brauer M et al. Jan 2022 Org Lett Discovery of a Cryptic Nitro Intermediate in the Biosynthesis of the 3-(trans-2'-Aminocyclopropyl)alanine Moiety of Belactosin A Autoren Engelbrecht A et al. Jan 2022 Ann Hematol Management of herpesvirus reactivations in patients with solid tumours and hematologic malignancies: update of the Guidelines of the AGIHO of the DGHO on herpes simplex virus type 1, herpes simplex virus type 2, and varicella zoster virus Autoren Henze L et al. Pagination Previous page ‹‹ Seite 100 Seite 101 Seite 102 Seite 103 Current page 104 Seite 105 Seite 106 Seite 107 Seite 108 Seite 100 Seite 101 Seite 102 Seite 103 Seite 104 Seite 105 Seite 106 Seite 107 Seite 108 Next page ››
Jan 2022 mBio Overcoming the Barrier of the Respiratory Epithelium during Canine Distemper Virus Infection Autoren Shin DL et al.
Jan 2022 Internist (Berl) [Practical use of digital health applications (DiGA) in internal medicine] Autoren Mittermaier M et al.
Jan 2022 Infect Genet Evol Molecular epidemiology of respiratory syncytial virus in hospitalised children in Heidelberg, Southern Germany, 2014-2017 Autoren Tabatabai J et al.
Jan 2022 Euro Surveill Impact of single-room contact precautions on acquisition and transmission of vancomycin-resistant enterococci on haematological and oncological wards, multicentre cohort-study, Germany, January−December 2016 Autoren Biehl LM et al.
Jan 2022 PLoS One Longitudinal variability in the urinary microbiota of healthy premenopausal women and the relation to neighboring microbial communities: A pilot study Autoren Biehl LM et al.
Jan 2022 Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz [Bulevirtide as the first specific agent against hepatitis D virus infections-mechanism and clinical effect] Autoren Nkongolo S Hollnberger J Urban S
Jan 2022 Mol ther Ex vivo and in vivo suppression of SARS-CoV-2 with combinatorial AAV/RNAi expression vectors Autoren Becker J et al.
Jan 2022 Commun Biol SARS-CoV-2 infection induces a pro-inflammatory cytokine response through cGAS-STING and NF-κB Autoren Neufeldt CJ et al.
Jan 2022 Chem Sci Total synthesis and mechanism of action of the antibiotic armeniaspirol A Autoren Arisetti N et al.
Jan 2022 Clin Exp Immunol Deciphering the Plasmodium falciparum malaria-specific CD4+ T cell response: ex vivo detection of high frequencies of PD-1+TIGIT+ EXP1-specific CD4+ T cells using a novel HLA-DR11-restricted MHC class II tetramer Autoren Schulte S et al.
Jan 2022 PLoS Pathog Itaconate and derivatives reduce interferon responses and inflammation in influenza A virus infection Autoren Sohail A et al.
Jan 2022 J Virol Reduction of CD8 T cell functionality but not inhibitory capacity by integrase inhibitors Autoren Richter E et al.
Jan 2022 J Antimicrob Chemother An open randomized multicentre Phase 2 trial to assess the safety of DAV132 and its efficacy to protect gut microbiota diversity in hospitalized patients treated with fluoroquinolones Autoren Vehreschild M et al.
Jan 2022 Nat Commun Dynamics of spike-and nucleocapsid specific immunity during long-term follow-up and vaccination of SARS-CoV-2 convalescents Autoren Koerber N et al.
Jan 2022 Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz [Development approaches for vaccines against hepatitis C virus infections] Autoren Bankwitz D Krey T Pietschmann T
Jan 2022 Parasitol Res A qPCR to quantify Wolbachia from few Onchocerca volvulus microfilariae as a surrogate for adult worm histology in clinical trials of antiwolbachial drugs Autoren Schlabe S et al.
Jan 2022 Hepatology HCC and HBV reactivation-A preventable condition not to be missed Autoren Sandmann L Cornberg M
Jan 2022 Bioorg Med Chem Lett Novel 2,4-disubstituted quinazoline analogs as antibacterial agents with improved cytotoxicity profile: Modification of the benzenoid part Autoren Megahed SH et al.
Jan 2022 Front Immunol Editorial: Novel Concepts in Using Broadly Neutralizing Antibodies for HIV-1 Treatment and Prevention Autoren Wagh K et al.
Jan 2022 Cell Mol Immunol MCMV-based vaccine vectors expressing full-length viral proteins provide long-term humoral immune protection upon a single-shot vaccination Autoren Kim Y et al.
Jan 2022 Cell mRNA-based COVID-19 vaccine boosters induce neutralizing immunity against SARS-CoV-2 Omicron variant Autoren Garcia-Beltran WF et al.
Jan 2022 Gut Pathog Myxopyronin B inhibits growth of a Fidaxomicin-resistant Clostridioides difficile isolate and interferes with toxin synthesis Autoren Brauer M et al.
Jan 2022 Org Lett Discovery of a Cryptic Nitro Intermediate in the Biosynthesis of the 3-(trans-2'-Aminocyclopropyl)alanine Moiety of Belactosin A Autoren Engelbrecht A et al.
Jan 2022 Ann Hematol Management of herpesvirus reactivations in patients with solid tumours and hematologic malignancies: update of the Guidelines of the AGIHO of the DGHO on herpes simplex virus type 1, herpes simplex virus type 2, and varicella zoster virus Autoren Henze L et al.
